Bioengine Technology Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 130

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $43.8M

  • Investors
  • 11

Bioengine Technology General Information

Description

Developer of a bio-technical platform designed to offer animal cell research and development service. The company focuses on the research and development, and application of critical biotechnologies, including the large-scale high-density serum-free culture of animal cells and personalized serum-free medium raw materials, and provides technical support and key raw material and equipment support for pilot incubation, industrialization, and industrial production of biomedical products, enabling clients to improve biotechnological research efficiency and receive high-quality biomedical treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5F, Building 1, Lane 720, Cailun Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 5F, Building 1, Lane 720, Cailun Road
  • Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Bioengine Technology Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioengine Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 15-May-2023 $43.8M Completed Generating Revenue
7. Later Stage VC (Series B2) 29-Mar-2022 Completed Generating Revenue
6. Later Stage VC (Series B1) 06-Jul-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 26-Aug-2019 Completed Generating Revenue
4. Early Stage VC (Series A1) 15-Jun-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 19-Mar-2016 Completed Generating Revenue
2. Grant $2.9M $162K Completed Startup
1. Capitalization 24-Dec-2014 $162K $162K Completed Startup
To view Bioengine Technology’s complete valuation and funding history, request access »

Bioengine Technology Executive Team (1)

Name Title Board Seat
Wensong Tan Ph.D Founder & Chairman
To view Bioengine Technology’s complete executive team members history, request access »

Bioengine Technology Board Members (1)

Name Representing Role Since
Wensong Tan Ph.D Bioengine Technology Founder & Chairman
To view Bioengine Technology’s complete board members history, request access »

Bioengine Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioengine Technology Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
HM Capital Venture Capital Minority
Kington Capital Venture Capital Minority
Leo Group Company Corporation Minority
NRL Capital Venture Capital Minority
Riverhead Capital (China) Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Bioengine Technology FAQs

  • When was Bioengine Technology founded?

    Bioengine Technology was founded in 2014.

  • Who is the founder of Bioengine Technology?

    Wensong Tan Ph.D is the founder of Bioengine Technology.

  • Where is Bioengine Technology headquartered?

    Bioengine Technology is headquartered in Shanghai, China.

  • What is the size of Bioengine Technology?

    Bioengine Technology has 130 total employees.

  • What industry is Bioengine Technology in?

    Bioengine Technology’s primary industry is Biotechnology.

  • Is Bioengine Technology a private or public company?

    Bioengine Technology is a Private company.

  • What is the current valuation of Bioengine Technology?

    The current valuation of Bioengine Technology is .

  • What is Bioengine Technology’s current revenue?

    The current revenue for Bioengine Technology is .

  • How much funding has Bioengine Technology raised over time?

    Bioengine Technology has raised $93.3M.

  • Who are Bioengine Technology’s investors?

    HM Capital, Kington Capital, Leo Group Company, NRL Capital, and Riverhead Capital (China) are 5 of 11 investors who have invested in Bioengine Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »